Tourmaline Bio Inc.

12.39
-0.70 (-5.35%)
At close: Mar 03, 2025, 3:59 PM
12.33
-0.48%
After-hours: Mar 03, 2025, 04:00 PM EST

Tourmaline Bio Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 33K 6K 623K 447K 379K
Gross Profit -33K -6K -623K -447K -379K
Operating Income -45.41M -19.7M -904 -22.68M -18.38M
Interest Income n/a n/a n/a n/a 223K
Pretax Income -42.12M -19.7M -904 -22.71M -18.16M
Net Income -42.12M -19.7M -904 -22.71M -18.16M
Selling & General & Admin 13.04M 2.17M 692.00 6.96M 4.63M
Research & Development 32.37M 17.53M 212.00 15.28M 13.37M
Other Expenses n/a n/a n/a n/a n/a
Operating Expenses 45.41M 19.7M 904.00 22.24M 18M
Interest Expense n/a n/a n/a 23K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 45.41M 19.7M 904.00 22.68M 18.38M
Income Tax n/a n/a -47.21M n/a n/a
Shares Outstanding (Basic) 4.75M 20.34M 10.88M 668.51K 4.13M
Shares Outstanding (Diluted) 4.75M 20.34M 10.88M 668.51K 4.13M
EPS (Basic) -8.87 -0.97 -0.00 -33.97 -4.39
EPS (Diluted) -8.87 -0.97 -0.00 -33.97 -4.39
EBITDA -45.38M -19.7M -46.88M -22.24M -17.78M
Depreciation & Amortization 33K 6K 904.00 447K 379K